Balyasny Asset Management LLC Legend Biotech Corp Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 681,174 shares of LEGN stock, worth $23.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
681,174
Previous 451,965
50.71%
Holding current value
$23.2 Million
Previous $20 Million
65.82%
% of portfolio
0.06%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$381 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$256 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$226 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$195 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$172 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.71B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...